Jessica Kim Cohen

In the PGx-ACT trial, investigators are tracking if patients unable to fully benefit from hydrocodone, tramadol, or codeine can get on the right drug with the help of genetic testing.

Initial findings from the country's 10-year National Precision Medicine program could yield genetic tests tailored to Asian populations within Singapore and abroad.

While four genetic mutations have been associated with the risk of developing PML, there is not consensus on which drugs merit preventive screening.

Researchers from Henry Ford Health in Detroit hope to prospectively validate the pharmacogenomics PRS's ability to predict survival benefit for patients on beta blockers.

The Precision Diagnosis Study offers whole-genome sequencing to First Nations, Métis, and Inuit patients with suspected genetic conditions.

University of Cambridge researchers said at the American College of Cardiology annual meeting that they plan to make the PRS and AI tool publicly available through an online app.

Researchers analyzed electronic health and claims records to discover very low genetic testing rates among patients with five inherited cardiovascular conditions.

In multiple presentations, researchers at ACC/WCC's annual meeting explored the impact of genotyping cardiac patients within a week of starting dual anti-platelet therapy.

Patients in Florida and New Jersey can request a $199 video consultation with a pharmacist to interpret pharmacogenetic test results from approved labs.

A chat-based approach to genetic counseling, in which counselors and patients send messages back and forth through an online portal, could increase patient access.